Internal Medicine Doctors in Granby, CT Accepting Medicare
6 Internal Medicine doctors found. Showing 1 - 6
 Betty Kupracz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 18 E Granby Rd, Granby, CT 06035 Phone: 860-653-7261 Fax: 860-653-6639 |
 Joseph Maglio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 18 East Granby Road, 1st Floor, Granby, CT 06035 Phone: 860-653-7261 Fax: 860-653-6639 |
Donna-marie E Christie, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 18 East Granby Rd, Granby, CT 06035 Phone: 860-653-7261 Fax: 860-653-6639 |
Michele Twigg, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 18 E. Granby Rd, 1st Floor, Granby, CT 06035 Phone: 860-653-7261 Fax: 860-653-6639 |
Dr. William Stewart Blomquist, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 15 Tennyson Dr, Granby, CT 06035 Phone: 860-653-7725 |
Dr. Peter Edward Barwick, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 10 Haven Dr, Granby, CT 06035 Phone: 180-653-3023 |
News Archive
Fleming ramps up production of ThyroShield to meet increased domestic and international demand
Fleming Pharmaceuticals, maker of ThyroShield– the only FDA approved liquid potassium iodide product indicated for thyroid protection in radiation emergencies – announced today that it has implemented the changes necessary to ramp up production to meet increased domestic and international demand.
Study reveals brain mechanism involved in switching between habitual behavior and decision-making
Not all habits are bad. Some are even necessary. It's a good thing, for example, that we can find our way home on "autopilot" or wash our hands without having to ponder every step. But inability to switch from acting habitually to acting in a deliberate way can underlie addiction and obsessive compulsive disorders.
When it comes to pain - mind over matter works
According to experts in the U.S., they have strong scientific proof that mind over matter works for relieving pain.
Cipher Pharmaceuticals enrolls first patient in Phase III study of CIP-ISOTRETINOIN
Cipher Pharmaceuticals Inc. today announced that it has enrolled the first patient in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne.
› Verified 8 days ago